ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Short Sessions of HRV Biofeedback

Not Applicable

Completed

Conditions: Resilience

Interventions: Behavioral: HRV Biofeedback

First Posted Date: 2023-07-24

Last Posted Date: 2023-07-24

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 127

Registration Number: NCT05958329

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Community-based Implementation of Online EmReg

Not Applicable

Recruiting

Conditions: Emotion Regulation
Traumatic Brain Injury

Interventions: Behavioral: Online EmReg
Behavioral: Consultation Sessions

First Posted Date: 2023-07-06

Last Posted Date: 2024-08-02

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 50

Registration Number: NCT05933629

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression

Not Applicable

Recruiting

Conditions: Major Depressive Disorder

Interventions: Device: Siemens 7T MRI
Device: Sham Neurofeedback

First Posted Date: 2023-07-06

Last Posted Date: 2024-06-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 80

Registration Number: NCT05933148

Locations: 🇺🇸
Icahn School Of Medicine at Mount Sinai, New York, New York, United States

Behavioral and Pharmacological Reconsolidation Interference in Misophonia

Early Phase 1

Completed

Conditions: Misophonia

Interventions: Drug: Propranolol Hydrochloride tablet
Behavioral: Reminder
Drug: Placebo
Behavioral: Counterconditioning

First Posted Date: 2023-07-03

Last Posted Date: 2024-10-16

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 141

Registration Number: NCT05928689

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Narcotic-Free Percutaneous Nephrolithotomy

Phase 4

Recruiting

Conditions: Nephrolithiasis

Interventions: Drug: 5mg Oxycodone, Q6 PRN
Drug: 10mg Ketorolac, Q6 PRN

First Posted Date: 2023-06-29

Last Posted Date: 2024-05-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 90

Registration Number: NCT05924165

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States

MTC Versus FMT in for RCDI

Phase 1

Recruiting

Conditions: Clostridiodies Difficile Infections

Interventions: Drug: MTC 01
Drug: Fecal Microbiota Transplantation (FMT)

First Posted Date: 2023-06-22

Last Posted Date: 2024-06-17

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 60

Registration Number: NCT05911997

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Heart Rate Variability (HRV) Biofeedback to Treat Ulcerative Colitis

Not Applicable

Not yet recruiting

Conditions: Ulcerative Colitis

Interventions: Behavioral: HRV biofeedback

First Posted Date: 2023-06-07

Last Posted Date: 2024-12-12

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 23

Registration Number: NCT05892159

Ritlecitinib in CTCL

Phase 2

Recruiting

Conditions: CTCL
Sezary Syndrome
Mycosis Fungoides

Interventions: Drug: Ritlecitinib

First Posted Date: 2023-05-30

Last Posted Date: 2024-05-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 20

Registration Number: NCT05879458

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE

Phase 4

Recruiting

Conditions: Labor

Interventions: Drug: Normal Saline Placebo
Drug: Ephedrine

First Posted Date: 2023-05-24

Last Posted Date: 2024-05-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 150

Registration Number: NCT05873218

Locations: 🇺🇸
Icahn School of Medicine at Mount SInai, New York, New York, United States

Dupilumab in the Treatment of Pediatric Alopecia Areata

Phase 2

Recruiting

Conditions: Alopecia Areata

Interventions: Drug: Placebo
Drug: Dupilumab

First Posted Date: 2023-05-19

Last Posted Date: 2024-10-18

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 76

Registration Number: NCT05866562

Locations: 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy